ag 127 and Shock, Septic

ag 127 has been researched along with Shock, Septic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bacher, J; Banks, SM; Danner, RL; Eichacker, PQ; Elin, RJ; Freeman, BD; Gazit, A; Hoffman, A; Levitzki, A; Natanson, C; Novogrodsky, A; Quezado, ZM; Sevransky, JE; Shaked, G; Thomas, ML	1

Other Studies

1 other study(ies) available for ag 127 and Shock, Septic

Article	Year
Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. The Journal of clinical investigation, 1997, Apr-15, Volume: 99, Issue:8 Topics: Animals; Benzylidene Compounds; Disease Models, Animal; Dogs; Enzyme Inhibitors; Escherichia coli Infections; gamma-Glutamyltransferase; Heart; In Vitro Techniques; Lung; Multiple Organ Failure; Nitriles; Peritonitis; Phenols; Protein-Tyrosine Kinases; Shock, Septic; Signal Transduction; Tumor Necrosis Factor-alpha; Tyrphostins	1997

Article

Year

Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.

The Journal of clinical investigation, 1997, Apr-15, Volume: 99, Issue:8

Topics: Animals; Benzylidene Compounds; Disease Models, Animal; Dogs; Enzyme Inhibitors; Escherichia coli Infections; gamma-Glutamyltransferase; Heart; In Vitro Techniques; Lung; Multiple Organ Failure; Nitriles; Peritonitis; Phenols; Protein-Tyrosine Kinases; Shock, Septic; Signal Transduction; Tumor Necrosis Factor-alpha; Tyrphostins

1997